Author/Authors :
Yenigun, Ezgi Coskun Department of Nephrology - Ankara Numune Research and Education Hospital, Ankara, Turkey , Bayrakci, Nergiz Department of Nephrology - Ankara Numune Research and Education Hospital, Ankara, Turkey , Cevher, Simal Koksal Department of Nephrology - Ankara Numune Research and Education Hospital, Ankara, Turkey , Ozkayar, Nihal Department of Nephrology - Ankara Numune Research and Education Hospital, Ankara, Turkey , Dede, Fatih Department of Nephrology - Ankara Numune Research and Education Hospital, Ankara, Turkey
Abstract :
Erythropoiesis-stimulating agents (ESAs) play an important role in
the management of anemia in patients with chronic kidney disease,
but the goals cannot be reached in 5% to 10% of the patients despite
high-dose ESA treatment. In case of ESA resistance, all causes of
anemia encountered in the general population should be carefully
reviewed. We present a patient examined for ESA resistance that
was diagnosed with systemic lupus erythematosus and subsequently
showed improvement of anemia with systemic corticosteroids.
